Stemcell Research Inc.

ABOUT US

We inform the world about treatment methods and technologies, practical applications of patents, joint research and development, and the commercialization of DFAT super cells.
We operate cell processing centers (CPC) and cell banks.
 

Company Profile

Company Name Stemcell Research Inc.
Headquarters Address 1-11-4 Hiroo, Shibuya, Tokyo
Executives Representative Director:Ryuji Sugawara
Director:Takaaki Tokunaga
Capital Stock 2,000,000 yen
Activities Patent holder for various patents, operation of cell processing center and cell culturing factory
Primary Bank MUFG Bank

DFAT cells were used Treatment for small animals

Regenerative medicine What is DFAT cell?

What is DFAT-derived supernatant?

PAGETOP
Copyright © Stemcell Holdings Limited. All Rights Reserved.
Powered by WordPress & BizVektor Theme by Vektor,Inc. technology.